Literature DB >> 28445378

The Impact of Body Mass Index on Abdominal Wall Reconstruction Outcomes: A Comparative Study.

Salvatore A Giordano1,2, Patrick B Garvey1,2, Donald P Baumann1,2, Jun Liu1,2, Charles E Butler1,2.   

Abstract

BACKGROUND: Obesity and higher body mass index may be associated with higher rates of wound healing complications and hernia recurrence rates following complex abdominal wall reconstruction. The authors hypothesized that higher body mass indexes result in higher rates of postoperative wound healing complications but similar rates of hernia recurrence in abdominal wall reconstruction patients.
METHODS: The authors included 511 consecutive patients who underwent abdominal wall reconstruction with underlay mesh. Patients were divided into three groups on the basis of preoperative body mass index: less than 30 kg/m (nonobese), 30 to 34.9 kg/m (class I obesity), and 35 kg/m or greater (class II/III obesity). The authors compared postoperative outcomes among these groups.
RESULTS: Class I and class II/III obesity patients had higher surgical-site occurrence rates than nonobese patients (26.4 percent versus 14.9 percent, p = 0.006; and 36.8 percent versus 14.9 percent, p < 0.001, respectively) and higher overall complication rates (37.9 percent versus 24.7 percent, p = 0.007; and 43.4 percent versus 24.7 percent, p < 0.001, respectively). Similarly, obese patients had significantly higher skin dehiscence (19.3 percent versus 7.2 percent, p < 0.001; and 26.5 percent versus 7.2 percent, p < 0.001, respectively) and fat necrosis rates (10.0 percent versus 2.1 percent, p = 0.001; and 11.8 percent versus 2.1 percent, p < 0.001, respectively) than nonobese patients. Obesity class II/III patients had higher infection and seroma rates than nonobese patients (9.6 percent versus 4.3 percent, p = 0.041; and 8.1 percent versus 2.1 percent, p = 0.006, respectively). However, class I and class II/III obesity patients experienced hernia recurrence rates (11.4 percent versus 7.7 percent, p = 0.204; and 10.3 percent versus 7.7 percent, p = 0.381, respectively) and freedom from hernia recurrence (overall log-rank, p = 0.41) similar to those of nonobese patients.
CONCLUSION: Hernia recurrence rates do not appear to be affected by obesity on long-term follow-up in abdominal wall reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, II.

Entities:  

Mesh:

Year:  2017        PMID: 28445378      PMCID: PMC5407296          DOI: 10.1097/PRS.0000000000003264

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  44 in total

1.  Minimally invasive component separation with inlay bioprosthetic mesh (MICSIB) for complex abdominal wall reconstruction.

Authors:  Charles E Butler; Kristin Turza Campbell
Journal:  Plast Reconstr Surg       Date:  2011-09       Impact factor: 4.730

Review 2.  Naturally Occurring Wound Healing Agents: An Evidence-Based Review.

Authors:  E G Karapanagioti; A N Assimopoulou
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

Review 3.  Mesh Location in Open Ventral Hernia Repair: A Systematic Review and Network Meta-analysis.

Authors:  Julie L Holihan; Duyen H Nguyen; Mylan T Nguyen; Jiandi Mo; Lillian S Kao; Mike K Liang
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

4.  Concurrent gastric bypass and repair of anterior abdominal wall hernias.

Authors:  Rob Schuster; Myriam J Curet; Ramzi S Alami; John M Morton; Sherry M Wren; Bassem Y Safadi
Journal:  Obes Surg       Date:  2006-09       Impact factor: 4.129

5.  Epidemiology and cost of ventral hernia repair: making the case for hernia research.

Authors:  B K Poulose; J Shelton; S Phillips; D Moore; W Nealon; D Penson; W Beck; M D Holzman
Journal:  Hernia       Date:  2011-09-09       Impact factor: 4.739

6.  Concurrent panniculectomy with open ventral hernia repair has added risk versus ventral hernia repair: an analysis of the ACS-NSQIP database.

Authors:  John P Fischer; Charles T Tuggle; Ari M Wes; Stephen J Kovach
Journal:  J Plast Reconstr Aesthet Surg       Date:  2014-01-28       Impact factor: 2.740

7.  A 5-year clinical experience with single-staged repairs of infected and contaminated abdominal wall defects utilizing biologic mesh.

Authors:  Michael J Rosen; David M Krpata; Bridget Ermlich; Jeffrey A Blatnik
Journal:  Ann Surg       Date:  2013-06       Impact factor: 12.969

8.  Laparoscopic ventral hernia repair (LVHR) in morbidly obese patients.

Authors:  Z Tsereteli; B A Pryor; B T Heniford; A Park; G Voeller; B J Ramshaw
Journal:  Hernia       Date:  2007-12-04       Impact factor: 4.739

Review 9.  Biologic versus nonbiologic mesh in ventral hernia repair: a systematic review and meta-analysis.

Authors:  Ali Darehzereshki; Melanie Goldfarb; Joerg Zehetner; Ashkan Moazzez; John C Lipham; Rodney J Mason; Namir Katkhouda
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

10.  Abdominal wall reconstruction: lessons learned from 200 "components separation" procedures.

Authors:  Jason H Ko; Edward C Wang; David M Salvay; Benjamin C Paul; Gregory A Dumanian
Journal:  Arch Surg       Date:  2009-11
View more
  13 in total

1.  Cutting through the fat: a retrospective analysis of clinical outcomes, cost, and quality of life with the addition of panniculectomy to ventral hernia repair in overweight patients.

Authors:  C E Hutchison; I A Rhemtulla; J T Mauch; R B Broach; F A Enriquez; J A Hernandez; C A Messa; N N Williams; S P Harbison; J P Fischer
Journal:  Hernia       Date:  2019-08-16       Impact factor: 4.739

2.  Impact of body mass index on minimally invasive ventral hernia repair: an ACS-NSQIP analysis.

Authors:  L Owei; R A Swendiman; S Torres-Landa; D T Dempsey; K R Dumon
Journal:  Hernia       Date:  2019-04-20       Impact factor: 4.739

3.  Effect of stapled versus layered skin closure on surgical site occurrences after abdominal wall reconstruction.

Authors:  Bryana Baginski; Regan Van Metre; Quinn Elliott; Jeremy A Warren; J Alex Ewing; William S Cobb; Alfredo M Carbonell
Journal:  Surg Endosc       Date:  2022-05-12       Impact factor: 4.584

4.  Plasma and Interstitial Fluid Pharmacokinetics of Prophylactic Cefazolin in Elective Bariatric Surgery Patients.

Authors:  Rochelle L Ryan; Dwane Jackson; George Hopkins; Victoria Eley; Rebecca Christensen; Andre A J Van Zundert; Steven C Wallis; Jeffrey Lipman; Suzanne L Parker; Jason A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2022-06-28       Impact factor: 5.938

Review 5.  Building a Center for Abdominal Core Health: The Importance of a Holistic Multidisciplinary Approach.

Authors:  Austin P Seaman; Kathryn A Schlosser; Daniel Eiferman; Vimal Narula; Benjamin K Poulose; Jeffrey E Janis
Journal:  J Gastrointest Surg       Date:  2022-01-10       Impact factor: 3.267

6.  Surgical site occurrences, not body mass index, increase the long-term risk of ventral hernia recurrence.

Authors:  Joshua S Jolissaint; Bryan V Dieffenbach; Thomas C Tsai; Luise I Pernar; Brent T Shoji; Stanley W Ashley; Ali Tavakkoli
Journal:  Surgery       Date:  2020-02-13       Impact factor: 3.982

7.  Increased incidence of surgical site infection with a body mass index ≥ 35 kg/m2 following abdominal wall reconstruction with open component separation.

Authors:  Salvatore Docimo; Konstantinos Spaniolas; Michael Svestka; Andrew T Bates; Samer Sbayi; Jessica Schnur; Mark Talamini; Aurora D Pryor
Journal:  Surg Endosc       Date:  2018-10-22       Impact factor: 4.584

8.  Management of ventral hernia in patients with BMI > 30 Kg/m2: outcomes based on an institutional algorithm.

Authors:  S J Baig; P Priya
Journal:  Hernia       Date:  2020-10-12       Impact factor: 4.739

9.  A Comparative Trial of Incisional Negative-Pressure Wound Therapy in Abdominoplasty.

Authors:  Gerald M Abesamis; Shiv Chopra; Karen Vickery; Anand K Deva
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-05-16

10.  Impact of panniculectomy in complex abdominal wall reconstruction: a propensity matched analysis in 624 patients.

Authors:  Sharbel A Elhage; Matthew N Marturano; Eva B Deerenberg; Jenny M Shao; Tanushree Prasad; Paul D Colavita; Kent W Kercher; B Todd Heniford; Vedra A Augenstein
Journal:  Surg Endosc       Date:  2020-10-20       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.